Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
Warfarin tablets - INR-guided dosing with renal monitoring
Product / population
Adults; named product and route only. Selected dosing and renal summary, not the full prescribing information.
Renal method
INR-guided; no fixed CrCl/eGFR adjustment table.
Source revision
DailyMed updated 2025-10-07.
Retrieved
2026-09-05
Local review status
Locally included source-specific summary. Regimen differences are not automatically resolved.
Official
Warfarin tablets - INR-guided dosing with renal monitoring
NIH/NLM DailyMed - U.S. product labeling · Adults; named product and route only. Selected dosing and renal summary, not the full prescribing information.
Locally included source-specific summary. Regimen differences are not automatically resolved.
Dosing / renal protocol and limits
When CYP2C9/VKORC1 genotypes are not known, the label describes an initial 2-5 mg orally once daily and typical maintenance of 2-10 mg daily. These are orientation ranges, not a fixed prescription: select the dose by indication, INR response, interacting drugs and patient factors.
The label does not mandate an automatic renal reduction. Patients with renal impairment should have more frequent INR monitoring. Serious or fatal bleeding is the boxed warning; anticoagulant-related nephropathy is also relevant. A stable renal classification does not establish a stable warfarin dose.
RDM30-090-warfarin-1 · Source locator: Warfarin tablets - INR-guided dosing with renal monitoring; renal/dosing sections and stated qualifiers
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.